Brief: Codex Dna Inc - On Dec 22, 2021, Co Entered Into Research Collaboration And License Agreement With Pfizer Inc

Telesis Bio

29/12/2021 13:30

Dec 29 (Reuters) - Codex DNA Inc  DNAY.O :
    * CODEX DNA INC - ON DEC 22, 2021, CO ENTERED INTO RESEARCH
COLLABORATION AND LICENSE AGREEMENT WITH PFIZER INC
    * CODEX DNA INC - CO, PFIZER AGREED TO COLLABORATE TO
DEVELOP
IMPROVEMENTS TO CO’S EXISTING PROPRIETARY BIOXP PLATFORM
    * CODEX DNA INC - UNDER AGREEMENT, PFIZER TO MAKE UPFRONT
PAYMENT
TO CO OF $8 MILLION
    * CODEX DNA - IF CO MEETS CERTAIN MILESTONES, CO WILL BE
ELIGIBLE
TO GET ADDITIONAL $10 MILLION IN PAYMENTS FROM PFIZER RELATED TO
CONDUCT OF RESEARCH AND DEVELOPMENT PROGRAM
    * CODEX DNA INC - PFIZER HAS AGREED TO PAY CO UP TO $60
MILLION IN
SALES MILESTONES FOR PRODUCTS (OTHER THAN EXCLUSIVE PRODUCTS)
    * CODEX DNA INC - PFIZER HAS AGREED TO PAY CO UP TO UP TO
$180
MILLION IN SALES MILESTONES FOR EXCLUSIVE PRODUCTS
    * CODEX DNA - PFIZER TO MAKE MILESTONE PAYMENTS TO CO WITH
EACH
PRODUCT BEING ELIGIBLE FOR PAYMENTS UP TO $35 MILLION
    * CODEX DNA - PROVIDED AGREEMENT REMAINS IN PLACE, PFIZER
WILL PAY
ESCALATING ROYALTIES FROM LOW TO MID-FRACTION OF ONE PERCENT OF
NET SALES OF PRODUCTS
    * CODEX DNA - PFIZER TO MAKE MILESTONE PAYMENTS TO CO WITH
FIRST
EXCLUSIVE PRODUCT IN EACH EXCLUSIVE FIELD BEING ELIGIBLE FOR
PAYMENT OF UP TO $55 MILLION

Source text for Eikon: [https://bit.ly/3z6YDWt]
Further company coverage:  DNAY.O 

 ((Reuters.Briefs@thomsonreuters.com;))